Citation

Kimura Y, Aoki J, Kohno M, Ooka H, Tsuruo T, Nakanishi O.: P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel. Cancer Chemother Pharmacol, Volume 49 (4), 2002

Authors

Aoki J, Kimura Y, Kohno M, Nakanishi O., Ooka H, Tsuruo T

Journal

Cancer Chemother Pharmacol

Year

2002

DOI

10.1007/s00280-001-0419-x

PubMed

11914912

Machine-readable

REST APIRDF